Semaglutide: Uses, Side Effects & Warnings

Generic name: semaglutide

Dosage form: subcutaneous injection, tablet

Pregnancy & Lactation: Risk data available

What is Semaglutide?

Semaglutide (Wegovy, Ozempic, Rybelsus) is a medicine used for weight loss in specific patients, and to lower blood sugar levels and reduce the risk of major cardiovascular events such as heart attack or stroke in type two diabetes patients. Semaglutide is a GLP-1 agonist and works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying and reducing appetite.

Semaglutide is not for use in people with type 1 diabetes.

Each of the different brands of semaglutide (Wegovy, Ozempic, Rybelus) are FDA approved for different conditions.

What is the difference between Wegovy, Ozempic and Rybelus?

The different brands of semaglutide have different uses and different forms:

Wegovy (subcutaneous injection) is used for weight management for a specific group of patients and is given as a subcutaneous injection weekly.
Ozempic (subcutaneous injection) is used lower blood sugar levels for type two diabetic patients, along with diet and exercise. It is also used for diabetic patients who already have cardiovascular disease, to help lower the risk of major cardiovascular events such as heart attack or stroke. Ozempic is given as a subcutaneous injection weekly.
Rybelsus (tablet) is used to lower blood sugar levels for type two diabetic patients along with diet and exercise, and is taken as a tablet once a day.

Brand of semaglutide	Ozempic	Wegovy	Rybelsus
Form	subcutaneous injection	subcutaneous injection	tablet
Strength	0.25 mg or 0.5 mg dose pen, 1 mg dose pen, 2mg dose pen.	0.25 mg dose pen, 0.5 mg dose pen, 1 mg dose pen, 1.7 mg dose pen, 2.4 mg dose pen	3mg tablet, 7mg tablet, 14mg tablet
Dose	weekly	weekly	daily
Uses	Used to help control blood sugar levels in type 2 diabetic patients, it is used together with diet and exercise. It is also used to reduce the risk of major cardiac events such as heart attack and strokes in type 2 diabetic patients who already have cardiovascular disease.	Used for weight loss for patients who have an initial BMI (body mass index) of 30kg/m2 or greater or patients who have a BMI of 27kg/m2 or greater and also have least one weight-related condition, such as high blood pressure, type 2 diabetes and high cholesterol. It is use together with diet and exercise.	Used to help control blood sugar levels in type 2 diabetic patients, it is used together with diet and exercise.

Dosing information

Ozempic dose

Ozempic injection 0.25 mg or 0.5 mg dose pen.

Pen can deliver 0.25 mg or 0.5 mg doses.
2mg/1.5mL (1.34mg/mL)
Each 1.5 ml pen contains 8 doses of 0.25mg or 4 doses of 0.5mg.

Ozempic injection 1 mg dose pen.

Pen delivers a 1mg dose.
4mg/3mL (1.34mg/mL)
Each 3ml pen contains 4 doses.

Ozempic injection 2mg dose pen.

Pen delivers a 2mg dose.
8mg/3mL (2.68 mg/mL)
Each 3ml pen contains 4 doses.

Ozempic Recommended Dosage

Start Ozempic with a 0.25 mg subcutaneous injection (injection under the skin) once weekly for 4 weeks. The 0.25 mg dosage is intended for treatment initiation and is not effective for glycemic control.
After 4 weeks on the 0.25 mg dosage, increase the dosage to 0.5 mg once weekly.
If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage may be increased to 1 mg once weekly.
If additional glycemic control is needed after at least 4 weeks on the 1 mg dosage, the dosage may be increased to 2 mg once weekly. The maximum recommended dosage is 2 mg once weekly.
Administer Ozempic once weekly, on the same day each week, at any time of the day, with or without meals.
The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours).
If a dose is missed, administer Ozempic as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule

Wegovy dose

Strengths available:

Wegovy 0.25 mg pen delivers one 0.25 mg dose (0.25 mg/0.5 mL)
Wegovy 0.5 mg pen delivers one 0.5 mg dose (0.5 mg / 0.5 mL)
Wegovy 1 mg pen delivers one 1 mg dose (1 mg / 0.5 mL)
Wegovy 1.7 mg pen delivers one 1.7 mg dose (1.7 mg / 0.75 mL)
Wegovy 2.4 mg pen delivers one 2.4 mg dose (2.4 mg / 0.75 mL)

Wegovy Recommended Dosage

Initiate Wegovy with a dose of 0.25 mg injected subcutaneously once-weekly and follow the dose escalation schedule below to minimize gastrointestinal adverse reactions

Week 1 to week 4: 0.25mg weekly
Week 5 to week 8: 0.5mg weekly
Week 9 to week 12: 1mg weekly
Week 13 to week 16: 1.7mg weekly
Week 17 onwards: 2.4mg weekly

If patients do not tolerate a dose during dose escalation, consider delaying dose escalation for 4 weeks
The maintenance dose of Wegovy is 2.4 mg injected subcutaneously once-weekly.
If patients do not tolerate the maintenance 2.4 mg once-weekly dose, the dose can be temporarily decreased to 1.7 mg once-weekly, for a maximum of 4 weeks. After 4 weeks, increase Wegovy to the maintenance dose of 2.4 mg once-weekly.
Discontinue Wegovy if the patient cannot tolerate the 2.4 mg dose.
In patients with type 2 diabetes, monitor blood glucose prior to starting Wegovy and during Wegovy treatment.

Rybelsus dose

Rybelsus tablets strengths are available in 3mg, 7mg, and 14mg

Take Rybelsus at least 30 minutes before the first food, beverage, or other oral medications of the day with no more than 4 ounces of plain water only. After 30 minutes of taking the tablet you may eat, drink or take other oral medicines. Swallow tablets whole. Do not split, crush, or chew tablets.

Rybelsus Recommended Dosage

Start Rybelsus with 3 mg once daily for 30 days. The 3 mg dose is intended for treatment initiation and is not effective for glycemic control.
After 30 days on the 3 mg dose, increase the dose to 7 mg once daily.
Dose may be increased to 14 mg once daily if additional glycemic control is needed after at least 30 days on the 7 mg dose.
Taking two 7 mg Rybelsus tablets to achieve a 14 mg dose is not recommended.
If a dose is missed, the missed dose should be skipped, and the next dose should be taken the following day.

Switching Patients between Ozempic and Rybelsus

Patients treated with Rybelsus 14 mg daily can be transitioned to Ozempic subcutaneous injection 0.5 mg once weekly. Patients can start Ozempic the day after their last dose of Rybelsus.
Patients treated with once weekly Ozempic 0.5 mg subcutaneous injection can be transitioned to Rybelsus 7 mg or 14 mg. Patients can start Rybelsus up to 7 days after their last injection of Ozempic. There is no equivalent dose of Rybelsus for Ozempic 1 mg.

General semaglutide dosing information

Ozempic and Wegovy are injected under the skin, usually once per week at any time of the day, with or without food. Use an injection on the same day each week.

Read and follow all instructions you have been given. Ask your doctor or pharmacist if you need help.

Prepare an injection only when you are ready to give it. Call your pharmacist if the medicine looks cloudy, has changed colors, or has particles in it.

Your healthcare provider will show you where to inject semaglutide. Do not inject into the same place two times in a row.

If you choose a different weekly injection day, start your new schedule after at least 2 days have passed since the last injection you gave.

Do not use different brands of semaglutide at the same time.

Blood sugar can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals.

Low blood sugar (hypoglycemia) can make you feel very hungry, dizzy, irritable, or shaky. To quickly treat hypoglycemia, eat or drink hard candy, crackers, raisins, fruit juice, or non-diet soda. Your doctor may prescribe glucagon injection in case of severe hypoglycemia.

Tell your doctor if you have frequent symptoms of high blood sugar (hyperglycemia) such as increased thirst or urination. Ask your doctor before changing your dose or medication schedule.

Your treatment may also include diet, exercise, weight control, medical tests, and special medical care.

You may get dehydrated during prolonged illness. Call your doctor if you are sick with vomiting or diarrhea, or if you eat or drink less than usual.

Store Rybelsus in the original package at room temperature, away from moisture and heat.

Store unopened Ozempic or Wegovy injection pens in the original carton in a refrigerator, protected from light. Do not use past the expiration date. Throw away an injection pen that has been frozen.

If needed, you may store an unopened Wegovy pen at cool room temperature for up to 28 days. Do not remove the cap until you are ready to use the injection pen. The pen contains a single dose. Throw the pen away after one use, even if there is still medicine left inside.

The Ozempic injection pen contains more than one dose. After your first use, store the pen with the needle removed in a refrigerator or at room temperature. Protect from heat and light. Keep the cap on when not in use. Throw the pen away 56 days after the first use, or if less than 0.25 mg is shown on the dose counter.

Do not reuse a needle. Place it in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.

Semaglutide Dosage information (more detail)

Source: https://themeditary.com/drug/semaglutide-5540.html?utm_source=blogger_source&utm_medium=blogger_medium&utm_campaign=blogger_cam

Drug Class: Incretin mimetics

Post by: TheMediTary.Com

Search This Blog

Drugs & Medications A to Z